71 results on '"Casanova, Ciro"'
Search Results
2. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study
3. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017
4. Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach
5. A longitudinal and multidesign epidemiological study to analyze the effect of the volcanic eruption of Tajogaite volcano (La Palma, Canary Islands). The ASHES study protocol
6. Analysis of Exposure and Respiratory Health Effects of Volcanic Eruption in the Canary Islands (ASHES). A SEPAR Study
7. The 7 Cardinal Sins of COPD in Spain
8. [Translated article] ANTES Program: One Year on
9. [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update
10. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
11. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos
12. ANTES: Un año después en la EPOC
13. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
14. Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC
15. [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome
16. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
17. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
18. WITHDRAWN: Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome
19. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD
20. Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
21. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD
22. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
23. High parathyroid hormone predicts exacerbations in COPD patients with hypovitaminosis D
24. Prevalence and Determinants of COPD in Spain: EPISCAN II
25. Sex differences between women and men with COPD: A new analysis of the 3CIA study
26. 10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain—A Summary of the EPISCAN II Protocol
27. Nuevo estudio sobre la prevalencia de la EPOC en España: resumen del protocolo EPISCAN II, 10 años después de EPISCAN
28. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes
29. Características de los pacientes con EPOC tratados en neumología en España según grupos GOLD y fenotipos clínicos GesEPOC
30. Temporal transitions in COPD severity stages within the GOLD 2017 classification system
31. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD
32. Shorter telomeres in non-smoking patients with airflow limitation
33. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
34. Documento de expertos del uso de broncodilatadores inhalados en monoterapia en el tratamiento de la EPOC estable leve-moderada
35. Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease
36. The variability of respiratory symptoms and associated factors in COPD
37. Consenso sobre el solapamiento de asma y EPOC (ACO) entre la Guía española de la EPOC (GesEPOC) y la Guía Española para el Manejo del Asma (GEMA)
38. Consensus on the Asthma–COPD Overlap (ACO) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)
39. Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable
40. Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary Disease
41. Chronic Obstructive Pulmonary Disease in Non-Smokers
42. Enfermedad pulmonar obstructiva crónica de origen no tabáquico
43. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO
44. Simplifying the Guidelines: The 10 COPD Commandments
45. Simplificando las guías: los 10 mandamientos de la EPOC
46. Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort
47. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD
48. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data
49. “Correct Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease”: A Consensus Document
50. Documento de consenso «Uso adecuado de los corticoides inhalados en la enfermedad pulmonar obstructiva crónica»
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.